Efficacy of amineptine in the prevention
of relapse in unipolar
depression
by
Ferreri M, Colonna L, Leger JM
Departement de Psychiatrie
et de Psychologie Medicale,
Centre
Hospitalo-Universitaire Saint-Antoine,
Paris, France.
Int Clin Psychopharmacol 1997 Jul; 12 Suppl 3:S39-45
ABSTRACT
The clinical properties of amineptine, a mainly dopaminergic antidepressant,
were assessed in a double-blind controlled study involving patients fulfilling
Diagnostic and Statistical Manual of Mental Disorders (DSM-III) criteria for
unipolar depression. The aim was to determine how relapses could be prevented in
this frequently recessing disorder. The study was a two-phase, 12-month,
multicentre trial of patients suffering from major depression or dysthymia,
diagnosed using DSM-III criteria and evaluated on the Montgomery-Asberg
Depression Rating Scale and the Mood, Anxiety, Retardation, Danger scale. Phase
I was an open-label 3-month period, with the patients being given 200 mg
amineptine per day. The second, 9-month period was a placebo-controlled
prophylactic phase. A total of 458 patients were initially included in the
study. Of the 376 who completed phase I, 303 (66%) were responders; 284 entered
the prophylactic study, randomly assigned to two groups. Of the 134 patients in
the placebo group who completed phase II, 25 (18.7%) suffered a relapse,
compared with nine out of the 136 (6.6%) in the amineptine group. After
resolution of an acute episode of major depression or dysthymia, long-term
antidepressant therapy with amineptine significantly reduced the relapse rate.
Efficacy
Structure
Metabolism
Early onset
Comparisons
Pharmacology
Pharmacokinetics
Amineptine excess
Amineptine and sex
Mesolimbic dopamine
Amineptine and smart mice
Amineptine and smarter dogs
Dopamine, opioids and learned helplessness
Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best to Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To
Healthy Mood Boosters For All The Family